Skip to content

Andrew Emerson

Joins IDEXX Laboratories as Executive Vice President, Chief Financial Officer · Nov 21, 2024 · SEC 8-KUnverified

Read the sourceProfile
Left
Not stated
Joined
IDEXX Laboratories
Executive Vice President, Chief Financial Officer

Why, in the source's words

On November 20, 2024, the Board appointed Andrew Emerson, currently Senior Vice President, Corporate and Companion Animal Group ("CAG") Finance of the Company, as Executive Vice President, Chief Financial Officer and Treasurer of the Company, effective March 1, 2025.
IDEXX Laboratories 8-K (SEC), filed 2024-11-21 , Nov 21, 2024
About this move
Type
Appointed
Role
Other
Announced
Nov 21, 2024
Effective
Not stated
Checked
Not yet: found by the daily agent

Sources: company leadership pages, SEC filings, press releases and news, with Wikipedia and Wikidata for the rest; moves from public announcements and 8-K filings. Roles as reported on the date shown. Logos via logo.dev; trademarks belong to their owners.

Leadership moves by email

Saturday mornings: the week's data and AI leadership moves, only when there are some.

Double opt-in. Unsubscribe any time.